Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The M2-1 protein is a critical transcription elongation and antitermination factor encoded by the respiratory syncytial virus (RSV). It is essential for efficient synthesis of full-length viral mRNAs and polycistronic readthrough mRNAs. M2-1 acts as both a transcriptional processivity factor and an antiterminator, preventing premature termination during viral mRNA synthesis. It also enables the RNA-dependent RNA polymerase (RdRp) to transcribe through gene end signals. The protein forms tetramers that interact competitively with both RNA and the phosphoprotein (P) and contains an N-terminal CCCH-type zinc finger motif essential for its function.
Inhibition of transcription elongation and antitermination
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Respiratory Syncytial Virus Transcription Elongation Factor M2-1 (M2-1).